Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis.
about
Onychomycosis due to Ulocladium botrytis.Treatment options--development of consensus guidelines.Impact of the antiproliferative agent ciclopirox olamine treatment on stem cells proteomeNail penetration and predicted mycological efficacy of an innovative hydrosoluble ciclopirox nail lacquer vs. a standard amorolfine lacquer in healthy subjects.Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathwayOnychomycosis: strategies to improve efficacy and reduce recurrence.Ciclopirox protects mitochondria from hydrogen peroxide toxicity.British Association of Dermatologists' guidelines for the management of onychomycosis 2014.Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy.Pharmacotherapy of onychomycosis.Current use of anti-infectives in dermatology.Toenail onychomycosis: current and future treatment options.Iontophoretically enhanced ciclopirox delivery into and across human nail plate.An update on treatment of onychomycosis.Amorolfine vs. ciclopirox - lacquers for the treatment of onychomycosis.Contact-free inactivation of Trichophyton rubrum and Microsporum canis by cold atmospheric plasma treatment.The antitumor activity of the fungicide ciclopiroxAn upcoming drug for onychomycosis: Tavaborole.Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections.Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.Interaction between ciclopirox and acenocoumarol.Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis.Combined analysis of gene expression and genome binding profiles identified potential therapeutic targets of ciclopirox in Ewing sarcoma.Bioinformatics analysis reveals potential candidate drugs for cervical cancer.
P2860
Q33205973-A28E8359-1176-47ED-8227-181888F1C3B4Q33989540-D9532107-82DB-41A6-9026-5A12A8BF9C03Q34035345-996C7129-B1F6-401A-B4EF-288C8D4F086BQ34208200-3A72A571-5976-414F-AC96-A8D3D1F3A555Q34654450-6DAFB447-FD0F-4912-A01C-22A4B0DEF4F2Q35025770-EF59C07E-C287-4D9D-A8F0-4121FA9680CFQ35048923-C7ED07F4-ECD8-402C-BDA0-D51E915C0BEFQ35437556-6C8D9DDC-E9A1-4995-8BB0-0B8F375DD0F9Q36008679-BE1E17B3-74FD-4694-9F65-95BF0C7A269CQ36150713-01905F9B-DB58-49F2-A96F-8AE70AAAAB48Q36233506-2099CA1E-0C64-45E4-B21B-B7B7B37A0BE2Q36777965-F942949E-B208-4A06-B066-751A5D32ACA4Q37327540-DBB305DF-A15E-4911-99CA-9BFD2FF5A0A4Q38006059-75AC7E2C-147B-4F63-9D7C-3E3AE3370FC6Q38395475-1B62775C-DE77-47CC-9344-83CEE94DDEBBQ39352777-03B49715-4DF5-4628-A468-A635F3ACCAB9Q39728484-F2409054-5A68-4440-9355-C75F6BD53818Q40816117-2026F1A3-D852-45FD-96DA-8DBE9E6ED168Q41019142-A3A3299F-77E2-45A4-9FEA-C8C29E8EDE14Q41189526-24F3D7A0-73A2-4ED6-BF5D-3FA50F6D80DEQ45357617-6F4CDF8E-1E2C-4236-AF6B-59229662ECD2Q46905094-A22635FE-A1B5-4461-A0AC-2204DBAD2B9FQ50067605-B943B543-C0F1-450D-903B-5D2E7E2E344AQ54439891-841FBE45-DBD5-4001-A3A6-D2B0CBD38DB3
P2860
Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Dermatopharmacology of ciclopi ...... he treatment of onychomycosis.
@ast
Dermatopharmacology of ciclopi ...... he treatment of onychomycosis.
@en
Dermatopharmacology of ciclopi ...... he treatment of onychomycosis.
@nl
type
label
Dermatopharmacology of ciclopi ...... he treatment of onychomycosis.
@ast
Dermatopharmacology of ciclopi ...... he treatment of onychomycosis.
@en
Dermatopharmacology of ciclopi ...... he treatment of onychomycosis.
@nl
prefLabel
Dermatopharmacology of ciclopi ...... he treatment of onychomycosis.
@ast
Dermatopharmacology of ciclopi ...... he treatment of onychomycosis.
@en
Dermatopharmacology of ciclopi ...... he treatment of onychomycosis.
@nl
P356
P1476
Dermatopharmacology of ciclopi ...... he treatment of onychomycosis.
@en
P2093
P304
P356
10.1067/MJD.2000.109072
P407
P433
P577
2000-10-01T00:00:00Z